be easily inserted beyond an obstructing tumour, unless it resides at the carina. 6 The pathology of this tumour is interesting. While tracheal and bronchial adenomas are well reported in the paediatric age group, this cell type is extremely rare. Fortunately, it is benign, but there may be a risk of local recurrence. 7 Repeat endoscopy at regular intervals over the next few years will thus be necessary. Because of the rarity of this lesion at this age in this site, firm conclusions about its likely natural history cannot be made.
Phaeochromocytoma with Asthma D. M. HARGREAVES* Charing Cross Hospital, London, England Key Words: ANAESTHESIA: phaeochromocytoma; COMPLICATIONS: asthma Phaeochromocytoma is one of the rare causes of hypertension which is amenable to treatment by surgery. The anaesthetic management of such cases has been well documented in the literature. The combination of phaeochromocytoma with asthma poses further management problems, as therapy for either disease can have detrimental effects on the other. Reviews of such cases are rare: we discuss the management of our case and the possible pre-, per-and postoperative therapeutic implications.
CASE HISTORY A 14-year-old boy weighing 48 kg presented for further resection of a known right adrenal phaeochromocytoma. His first admission to hospital, one year previously, had been for severe hypertension with blood pressures of up to 2701160 mmHg, hypertensive encephalopathy and papilloedema. He had raised vanillylmandelic acid and noradrenaline assays. Preoperatively he was started on phenoxybenzamine and atenolol and later underwent right adrenalectomy. Following surgery his blood pressure settled, but he developed bronchospasm which necessitated treatment with nebulized salbutamol and intravenous aminophylline.
Subsequently he remained well for over a year before another asthma attack necessitated his admission to hospital. In April 1986 he began to develop sweating attacks and hypertension. Investigation revealed an elevated plasma noradrenaline of 2520 pg/ml (normal 1000 pg/ml). A metaiodobenzylguanidine scan showed increased activity in the right adrenal gland. One month prior to surgery he was started on phenoxybenzamine 10 mg daily. On the morning of the operation his blood pressure was 110/70 mmHg with a pulse of 80. Premedication consisted of oral pentobarbitone 100 mg two hours preoperatively and hydrocortisone 50 mg intramuscu1arly one hour preoperatively. Two peripheral lines, a multilumen central venous line and a left radial artery cannula were inserted under sedation with midazolam 5 mg, droperidol 7.5 mg and fentanyl 150 jlg.
Anaesthesia was induced with sodium thiopentone 250 mg and vecuronium 5 mg. His cords were sprayed with lignocaine, a 7.0 mm cuffed oral endotracheal tube was passed and he was ventilated with nitrous oxide 66%, oxygen 33% and isoflurane. No bronchospasm was noted at this point. A transient increase in blood pressure to 180/110 and a pulse rate of 120 occurred on intubation, but this rapidly settled. Anaesthesia progressed smoothly until manipulation of the adrenal tumour, at which point there was a sustained rise in blood pressure to 200/120 with a tachycardia of 120. An incremental dose of nitroglycerine was administered and resulted in a rapid fall in blood pressure. In view of this result, it was felt unwise to administer negative inotropes to control the tachycardia and instead neostigmine was given cautiously in divided doses to a total of 0.625 mg.
After surgery he was transferred, intubated, to the Intensive Care Unit where he was noted to have bronchospasm which was treated with nebulized terbutaline. One hour later, following return of adequate spontaneous ventilation, he was extubated. It was noticed that his blood glucose, which had been running at 13-16 mmol per litre preoperatively, returned to normal following removal of the tumour. The rest of his hospital admission was uncomplicated.
DISCUSSION
The anaesthetic management of phaeochromocytoma has been reviewed widely, but the combination with asthma has not. Three case reports have described the reappearance of bronchospasm in asthmatic Anaesthesia and Intensil'e Care. Vo!. 17. No. I. February. 1989 individuals following the resection of a catecholamine secreting tumour. 1-3 Two of these cases involved a predominantly noradrenaline secreting tumour and the other an adrenaline secreting one.
Bronchomotor tone is controlled by the balance between the parasympathetic and sympathetic nervous systems. Stimulation of beta-2 receptors in the lung causes bronchodilatation, but the role of the alpha receptors is not clear. Although some reports cast doubt on the presence of any alpha-adrenergic mechanisms in the bronchi,4 there appears to be more evidence in favour of their presence in sparse numbers in bronchi which, when stimulated, cause bronchoconstriction. 5 ,6 Furthermore, it has been shown that there is an increase in both numbers and responsiveness of these alphareceptors combined with a decreased responsiveness in beta-2 receptors in asthmatic individuals.7.8 Alpha blockers can cause bronchodilatation in these circumstances.
Noradrenaline and adrenaline are endogenous catecholamines with alpha and beta effects; noradrenaline has predominantly alpha actions and adrenaline predominantly beta actions. Noradrenaline can provoke bronchoconstriction after prior beta blockade, and this is more significant in asthmatic individuals. 5 ,7 It might seem possible, therefore, for an asthmatic individual to experience bronchospasm due to high circulating levels of noradrenaline, but this does not appear to occur. This may in part be due to noradrenaline inhibiting parasympathetic discharge by action at the autonomic ganglia. 9 • In phaeochromocytoma there may be a desensitization of beta-receptors due to a chronic excess of catecholamines, such that when catecholamine levels fall following surgery there is insufficient stimulation of beta-receptors and bronchospasm may occur. IO This helps explain the postoperative bronchospasm seen in such cases.
Traditional preoperative management of phaeochromocytoma involves the stabilization of blood pressure with alpha blockers such as phenoxybenzamine, adding beta-blockade if necessary to control tachycardia. However, beta-blockade in an asthmatic may result in severe bronchospasm and thus the preand postoperative control of tachycardia does pose problems, as occurred in our case. Our small dose of neostigmine was effective, but was not without the risk of bronchospasm.
From the other classes of antiarrhythmic agents available to us, only the calcium channel blockers have a place in the treatment of sinus tachycardia. Verapamil is such a drug, acting on the sino-atrial node to decrease automaticity and increase the refactory period at the atrio-ventricular node. It produces a 10-15% reduction in the rate of sinus rhythm and also produces coronary vasodilatation and some alpha blockade.
Calcium antagonists have been used in a wide variety of clinical situations including the control of hypertension. There have been reports recently of the anaesthetic management of phaeochromocytoma using the calcium antagonists nifedipine and nicardipine. II ,12 In addition to their direct action on the circulation, they also inhibit release of catecholamines by the adrenal medulla,13 and have been shown to play a beneficial role in preventing bronchospasm. 14 It would seem that verapamil might be useful in a patient such as ours to control tachycardia, while at the same time having a beneficial effect on blood pressure and bronchomotor tone.
While pharmacological control of phaeochromocytoma may cause problems in the asthmatic, conversely, therapy for asthma may aggravate phaeochromocytoma. It is known that the endogenous glucocorticoids • have a permissive action on catecholamines, allowing them to exert their effect and increasing the sensitivity of vascular smooth muscle to them. In adrenal insufficiency there is a flat dose-response to catecholamines. Administration of ACTH has been implicated in causing crises in phaeochromocytoma, and it seems that the treatment of asthma with steroids could similarly result in an increase in symptoms of phaeochromocytoma. To conclude, I would like to suggest what I feel is the optimum management of such a case. First, preoperative therapy should remain unaltered, with alpha blockade in the weeks prior to surgery and a generous nonbronchospastic premedication. After insertion of all lines, induction and intubation is carried out with a thiopentone/fentanyl/ vecuronium technique. Maintenance of anaesthesia is with oxygen/nitrous oxide and isoflurane; isoflurane is used because of its relative lack of arrhythmogenic effects in the presence of circulating catecholamines. A glyceryl trinitrate infusion should be immediately available for hypertensive crises. Intermittent boluses of verapamil can be used to control troublesome tachycardia; this may also be of benefit in reducing blood pressure and combating bronchospasm. Persistent bronchospasm should be treated with aminophylline. Otherwise anaesthesia should proceed along accepted lines with maintenance of normovolaemia, normocapnia and an adequate depth of anaesthesia.
The combination of these two pathologies poses interesting therapeutic problems, and both conditions must be considered when treatment for either is carried out.
The provision of anaesthesia and adequate operating conditions in the treatment of infants with congenital tracheal stenosis is particularly difficult when the stenosis cannot be bypassed by tracheal intubation. We describe the management of an infant in which balloon dilation of the trachea and then tracheoplasty under cardiopulmonary bypass were performed.
CASE REPORT
A 3 kg, one-month-old Chinese infant with a large patent ductus arteriosus, associated with a small ventricular septal defect, underwent surgery to ligate the patent ductus. Anaesthesia proceeded uneventfully. There were no apparent problems in intubating with a plain 3.0 mm endotracheal tube nor in ventilating the infant. At the end of the operation the child was extubated. Two days later the child became increasingly distressed with marked inspiratory efforts. Arterial blood gases with an FI02 0.4 were pH 7.13, PaC02 67 mmHg, Pa02 109 mmHg and base excess -11 mmolll. Intubation was unexpectedly difficult as resistance was encountered to the passage of an endotracheal tube more than 2 cm beyond the vocal cords and ventilation became impossible. A size 2.5 mm endotracheal tube was inserted and secured above the obstruction. Controlled ventilation with inflation pressures of 20-25 mmHg and an F I o 2 of 0.3 produced satisfactory blood gases. A chest X-ray excluded pneumothorax, aspiration or pulmonary congestion as causes of the respiratory failure. Echocardiography showed that the patent ductus had been adequately ligated and that left to right blood flow through the small ventricular septal defect was minimal. The diaphragm was seen to move normally on the echocardiograph. It was impossible to prevent the endotracheal tube from moving when the patient was turned during nursing care. At such times ventilation was clearly seen to be inadequate and was corrected by carefully extending the head. Two attempts to wean the intubated infant with CPAP failed due to respiratory distress with marked inspiratory efforts and carbon dioxide retention.
A CAT scan of the trachea performed two days later confirmed the suspicion of tracheal stenosis (Figure 1) . The stenosis was reported to be hourglass-shaped, 1.7 cm long with a diameter of 1 mm at its narrowest point ended 1 cm above the carina. Contrast tracheography and bronchoscopy were not
